Last reviewed · How we verify
Myatro
At a glance
| Generic name | Myatro |
|---|---|
| Also known as | Atropine 0.01%, Atropine 0.05% |
| Sponsor | University of Medicine and Pharmacy at Ho Chi Minh City |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy Comparison of 2 Low-dose Atropine Eye Drops in Vietnamese Children Myopia Management (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Myatro CI brief — competitive landscape report
- Myatro updates RSS · CI watch RSS
- University of Medicine and Pharmacy at Ho Chi Minh City portfolio CI